Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Post-Operative Insulin Resistance in Surgery
NCT02393573Terminated
- Sponsor
- McGill University Health Centre
- Start
- Nov 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in insulin resistance (IR) comparing Metformin with Placebo (2 arms). Primary endpoint: Change in fasting blood glucose. Started Nov 2015; status: terminated.
02
Drugs
metformin
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02393573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393573.